IQVIA Logo

Vaccine Credentials

respiratory-vaccines-header

• Seasonal and Pandemic Influenza
• Hemophilus influenzae B
• Respiratory Syncytial virus 
• Neisseria meningitidis
• Streptococcus pneumoniae
• Bordetella pertussis
• Corynebacterium diphtheriae
• Rhinovirus
• SARS-CoV-1
• SARS-CoV-2
• MERS
• hMPV 
• PIV

other-infectious-diseases-vaccines-header

  • Human papilloma virus
    • Adenovirus
  • Adeno-associated virus (AAV)
  • Coxsackie virus
  • Measles
  • Mumps
  • Rubella
  • Varicella Zoster
  • Tetanus
  • Staphylococcus aureus
  • Streptococcus agalactiae (GBS)
  • Lymphocytic choriomeningitis
  • mammarenavirus (LCMV)
  • Poliovirus
  • Vaccinia

enteric-vaccines-header

• Escherichia coli
• Shigella spp.
• Clostridium difficile
• Rotavirus
• Salmonella typhimurium

sexually-transmitted-vaccines-header

• Cytomegalovirus
• Herpes simplex virus -1/-2
• Hepatitis A, B, C
• Epstein Barr Virus
• HIV

vector-zoonotic-vaccines-header

• Chikungunya
• Zika
• Dengue
• Ebola
• Malaria
• West Nile
• Tick-borne encephalitis virus
• Yellow Fever
• Nipah

SARS-CoV Variants (VOCs/VOIs)

Variant Lineage Pseudovirus Neutralization Assay (PNA) ELISA
D614 NA X (validated) X (validated)
RBD NA NA X (validated)
Nucleocapsid NA NA X (validated)
D614G B.1 X (validated) X (Ag available)
Alpha B.1.1.7 X (optimized) X (Ag available)
Beta B.1.351 X (validated) X (Ag available)
Delta B.1.617.2 X (validated) X (Ag available)
Delta+ B.1.617.2 + K714N X (optimized) X (Ag available)
Epsilon B.1.429 X (optimized) X (Ag available)
Eta B.1.525 X (optimized) NA
Gamma P.1 X (optimized) X (Ag available)
Iota-1 and 2 B.1.526 X (optimized) X (Ag available)
Kappa B.1.617.1 X (optimized) On going
Lambda C.37 X (optimized) NA
Mu B.1.621 X (optimized) NA
Omicron BA.1/B.1.1.529.1 X (validated) X (qualified)
Omicron BA.2/B.1.1.529.2 X (validated) On going
Omicron BA.4/5; B.1.1.529.4/5 X (validated) On going
Omicron BA.2.75 X (optimized) On going
Theta P.3 X (optimized) NA
XBB.1 BA.2.10.1 X (optimized) On going
XBB 1.5 BA.2.10.5 X (optimized) On going
XBB 1.16 Close related to XBB 1.5 XBB 1.5 validated On going
XBB 1.9.1 Close related to XBB 1.5 X (optimized) On going
XBB 1.9.2 Close related to XBB 1.5 X (optimized) On going
BQ.1 BA.5 derivative X (optimized) On going
CH.1.1 Derivative Delta X (optimized) On going
Pirola BA.2.86 On going On going
SARS-CoV-1 NA X (optimized) On going
MERS NA X (optimized) On going

 

Various Pathogens

Pathogens Assay type Validation level
SARS-CoV-2 Spike (peptides) 14-colors ICS Qualified
SARS-CoV-2 Spike (peptides) IFNg ELISPOT Qualified
SARS-CoV-2 Spike (peptides) IFNg/IL-5 ELISPOT Qualified
RSV A2, A-Long, B µneutralization Qualified
Chikungunya virus µneutralization Qualified
Chikungunya virus ELISA Qualified
Anti-Pertactin ELISA Validated
Anti-Tetanus Toxoid ELISA Qualified
Anti-Filamentous Haemagglutinin (FHA) ELISA Qualified
Pertussis SBA Qualified
Anti-Pertussis ELISA Qualified
Anti-Diphteria Toxoid ELISA Qualified
Anti-VZV ELISA Qualified
Anti-Rubella ELISA Validated
Anti-Measles ELISA Validated
Anti-Mumps ELISA Validated
Anti-Haemophilus Influenza B (HiB) ELISA Validation ongoing
Anti-Hepatitis B (HepB) HBsAg ELISA Validation ongoing
Anti-Hepatitis A (HepA) ELISA Validation ongoing
24-plex Pneumococcal Polysaccharide Serotypes MSD Validation ongoing
24-plex Pneumococcal Polysaccharide Serotypes 24 WHO ELISAs Validation ongoing
24-Plex Pneumococca Multiplex Opsonophagocytosis Assay (MOPA) Qualification ongoing

 

Protein Sciences Product Catalog

Use the filters below to refine the table data. Adjust one or more criteria to find the information you need. Clear any filter to reset your results.